ICD-10 Code M05.A: Abnormal rheumatoid factor and ACPA (2026)

Key Takeaways

ICD-10 Code M05.A identifies rheumatoid arthritis with both positive rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA).

M05.A is itself billable, but it carries a Code First instructional note: sequence a site-specific rheumatoid arthritis with rheumatoid factor code (M05.00 to M05.8A) before it, never submit M05.A alone.

Documentation must confirm a diagnosed RA, a positive RF lab result, and a positive ACPA/anti-CCP result before coding M05.A.

Pabau’s claims management software supports accurate ICD-10 diagnostic code entry and claim submission for rheumatology practices.

Most rheumatoid arthritis denials tied to ICD-10 Code M05.A trace back to a sequencing mistake, not a billability one.

M05.A is itself a billable code, but the ICD-10-CM Official Guidelines require a "Code first" sequence: coders must select a site-specific rheumatoid arthritis with rheumatoid factor code (M05.00 to M05.8A) first, then add M05.A to flag double-seropositive disease (both RF and ACPA/anti-CCP positive).

Practices that submit M05.A on its own, without the required primary code, face automatic rejection. This reference covers everything needed to code M05.A correctly for FY2026, including the Code First sequencing rule, documentation checklist, and common errors that trigger denials.

ICD-10 Code M05.A: Definition and billable status

ICD-10 Code M05.A describes rheumatoid arthritis in a patient who tests positive for both rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA). It sits within the M05 category, rheumatoid arthritis with rheumatoid factor, inside the musculoskeletal chapter M00-M99, alongside related joint disorder codes such as M12.9.

The 2026 edition of ICD-10-CM made M05.A effective on October 1, 2025. According to icd10data.com, M05.A is itself a billable, specific code – the most specific code in its subcategory, with no 7th character and no child codes.

It carries a "Code first" instructional note requiring rheumatoid arthritis with rheumatoid factor by site, if known (M05.00 to M05.8A), to be coded first. Claims that list M05.A alone, without that preceding site-specific code, will be rejected.

ICD-10 Code M05.A Code First rule: Pairing with site-specific M05 codes

M05.A does not have a 7th character and does not have child codes – M05.A1 through M05.A9 do not exist. Instead, M05.A carries a "Code first" instructional note: coders must first assign a separately selected, site-specific rheumatoid arthritis with rheumatoid factor code from the M05.00-M05.8A range for the affected joint and any organ involvement.

Coders then add M05.A as a second code whenever the record confirms double-seropositive serology (both RF and ACPA/anti-CCP positive). According to icd10data.com, this is a manifestation/add-on convention, not a parent-child relationship.

Never submit M05.A as the first-listed or only diagnosis code – payers reject claims that list M05.A without a preceding site-specific M05.00-M05.8A code. Equally, do not add M05.A at all when the record does not confirm both a positive RF and a positive ACPA/anti-CCP result. In that case, code the site-specific M05 code alone.

Clinical significance of dual-positive serology (RF and ACPA)

The M05.A subcategory was created to capture a clinically distinct patient population. Patients with both abnormal rheumatoid factor and positive anti-citrullinated protein antibody (ACPA, also called anti-CCP) typically follow a more aggressive disease course than patients positive for only one marker.

This matters for rheumatology and musculoskeletal care workflows because treatment decisions, including earlier initiation of biologic therapy, often hinge on the dual-positive serology finding.

From a coding perspective, this clinical distinction means documentation must be explicit. A patient positive for RF alone may qualify for a different M05 subcategory. A patient positive for ACPA alone without confirmed RA diagnosis does not meet the criteria for M05.A at all. The code requires all three elements: confirmed RA diagnosis, abnormal RF, and positive ACPA.

According to clinical guidance from the American College of Rheumatology (ACR), dual-positive serology is associated with greater radiographic progression and may warrant earlier consideration of disease-modifying therapy. Clinicians should note this distinction in the medical record, as it directly supports adding M05.A alongside whichever site-specific or manifestation M05 code has already been selected.

ICD-10-CM code hierarchy: Where M05.A sits

Understanding the hierarchy clarifies why M05.A must be sequenced after a site-specific code rather than used alone. The ICD-10 musculoskeletal chapter organizes codes in layers, growing more specific at each level, the way M83.8 sits within its own subcategory. M05.A sits alongside the site-specific codes at the same depth, as an add-on rather than a level of its own.

• Chapter M00-M99: Diseases of the musculoskeletal system and connective tissue
• Block M05-M14: Inflammatory polyarthropathies
• Category M05: Rheumatoid arthritis with rheumatoid factor (seropositive RA)
• Site-specific codes M05.00-M05.8A: Billable, per-joint codes coded first, per the Code First instructional note
• Add-on code M05.A: Abnormal RF and ACPA with rheumatoid arthritis – billable, sequenced second, after the site-specific code

The M06 category covers seronegative rheumatoid arthritis, where the patient lacks rheumatoid factor. Never use M05.A when only ACPA is positive without confirmed RF, and never use M06 when RF is present. The serology result determines the correct top-level category. See the comparison table below.

M05.A vs other M05 subcategories: When to use each code

M05 contains several subcategories beyond M05.A, each describing a distinct clinical presentation. M05.A is not a substitute for any of them – it is an add-on that flags double-seropositive serology (RF and ACPA/anti-CCP both positive) on top of whichever site-specific or manifestation M05 code already applies.

Choosing the wrong subcategory, or omitting the required primary code, is a common payer audit finding in rheumatology practices. This table shows the key M05 subcategories and M06 alongside their clinical criteria, an approach not available on most ICD-10 reference sites.

Documentation requirements for ICD-10 Code M05.A

Payers require specific documentation before accepting M05.A alongside its site-specific code. Missing even one element creates a denial risk. Maintaining structured patient records with clearly separated fields for lab results and joint site findings keeps this documentation complete. Use digital intake forms to capture lab values at the point of care.

These four elements must appear in the medical record to support M05.A code selection, based on CMS ICD-10-CM coding requirements and ICD-10-CM Official Guidelines for Coding and Reporting FY2026:

• Confirmed RA diagnosis: The provider must document a confirmed diagnosis of rheumatoid arthritis, not just a suspicion or rule-out.
• Positive rheumatoid factor: The medical record must include an abnormal/positive RF lab result with the test date and result value.
• Positive ACPA/anti-CCP: A separate positive anti-citrullinated protein antibody result is required. RF alone does not justify M05.A.
• Specific joint site: The affected joint must be documented to select the correct site-specific M05.00-M05.8A code, which is coded first. M05.A is then added second. The provider’s note must name the joint.

Maintaining clinical documentation compliance across all four of these elements before coding significantly reduces payer audit exposure. Coders should not assign M05.A based on the provider’s verbal communication alone – the documentation must be in the record.

Coding guidelines and best practices

The ICD-10-CM Official Guidelines for Coding and Reporting govern how M05.A codes are applied in practice. Several rules directly affect how rheumatology practices submit claims for this patient population, the same sequencing logic coders apply elsewhere in the musculoskeletal chapter, including codes like M83.1.

• Never submit M05.A as the first-listed or only code: M05.A is billable, but its Code First note requires a site-specific M05 code (M05.00-M05.8A) to be sequenced before it. Claims listing M05.A without a preceding site-specific code will be rejected by payers.
• Select the most specific site-specific code first: Choose the M05.00-M05.8A code that matches the documented joint (and organ or systems involvement, if any) before adding M05.A.
• Sequence correctly with comorbidities: When RA is the reason for the visit, the site-specific M05 code is the principal/first-listed diagnosis, with M05.A reported as a secondary code. Comorbidities such as osteoporosis or cardiovascular involvement are coded additionally.
• Additional codes for manifestations: Some RA manifestations require an additional code under ICD-10-CM guidelines. Consult the tabular list instructional notes for the selected site-specific code to identify required additional codes.
• Match coding to the documented condition at discharge or encounter close: Do not code based on lab findings alone without a documented RA diagnosis in the provider’s assessment.

Common coding errors to avoid with ICD-10 Code M05.A

Denial patterns for M05.A codes cluster around a small set of consistent mistakes. This error-versus-correct-code table consolidates those patterns in one place, a format absent from most ICD-10 reference databases. Review it before submitting any M05.A claim.

How to use M05.A codes in practice management software

Getting the code right in the medical record is only half the workflow. The other half is accurate entry into the practice management system before claim submission. Practices using practice management software with integrated ICD-10 lookup avoid the manual transcription errors that often introduce the coding mistakes listed above.

When entering the site-specific code and M05.A, the workflow typically follows these steps:

1. Confirm lab values in the record: Before opening the code entry field, verify that both positive RF and positive ACPA results are documented in the patient chart for this encounter.
2. Select the site-specific code first: Enter the documented joint (for example, “right shoulder”) in the ICD-10 search field and choose the matching M05.00-M05.8A code as the first-listed diagnosis.
3. Add M05.A as the second code: If the chart confirms double-seropositive serology (RF and ACPA/anti-CCP both positive), search “M05.A” and add it directly after the site-specific code – never as the only diagnosis code.
4. Link the diagnosis codes to the procedure code: Attach both codes to the relevant CPT procedure code (such as 99213/99214 for the office visit or specific rheumatology procedure codes) before claim submission.
5. Review for additional code requirements: Check whether the tabular instructional notes for the selected site-specific code require any additional codes for associated manifestations.
6. Submit and track: Use claims management software to track the claim status and flag any M05.A-related denials for coding review.

Practice management software like Pabau supports this sequence with a built-in ICD-10 code search and claims workflow for rheumatology and musculoskeletal practices. Built-in data protection tools also ensure that lab results and diagnosis codes remain linked to the correct patient record throughout the billing cycle.

Streamline your ICD-10 coding and claims workflow

Pabau gives rheumatology and musculoskeletal practices a built-in ICD-10 code search, structured patient records, and integrated claims management so M05.A codes reach the payer correctly the first time.

Book a demo

Approximate synonyms and crosswalk terms

Several clinical and administrative terms map to the M05.A code family. Recognizing these synonyms helps coders identify when M05.A is the correct code even when the provider uses a different phrase in the documentation. The icd10data.com M05.A code page lists approximate synonyms for the code alongside its Code First instructional note.

• Seropositive rheumatoid arthritis with dual-positive serology
• RF-positive and anti-CCP-positive rheumatoid arthritis
• Rheumatoid arthritis with abnormal rheumatoid factor and anti-citrullinated peptide antibody
• Dual-positive RA (RF and ACPA)
• Anti-CCP-positive seropositive RA

Coders should also be aware that “anti-CCP” and “ACPA” refer to the same class of antibodies. Either term in provider documentation supports M05.A code selection when RF is also positive and RA is confirmed. Always verify that patient records stay up to date with the most recent lab result terminology used at the ordering facility.

Conclusion

M05.A denials almost always trace to a single preventable step: submitting M05.A without first sequencing the site-specific rheumatoid arthritis with rheumatoid factor code (M05.00-M05.8A) that the Code First note requires. Documentation must confirm all three elements (RA diagnosis, positive RF, positive ACPA) and name the affected joint before M05.A can be legitimately added alongside its required primary code.

Pabau’s claims management software keeps ICD-10 code entry, lab result documentation, and claim submission inside a single workflow, so rheumatology practices catch these issues before the payer does. To see how Pabau handles musculoskeletal and rheumatology coding workflows, book a demo.

Continue your research

Need the seronegative RA code? ICD-10 Code M06.9 covers rheumatoid arthritis without a confirmed positive rheumatoid factor result.

Looking for compliance guidance for your practice? Mandatory compliance for physiotherapy clinics covers documentation standards that apply across musculoskeletal specialties.

Want to automate your ICD-10 claim submissions? Pabau’s claims management software integrates ICD-10 code search directly into your billing workflow.

Frequently asked questions